Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor

Vivian Wai Yan Lui, Sufi Mary Thomas, Qing Zhang, Abbey Lynn Wentzel, Jill Marie Siegfried, Joyce Yan Li, Jennifer Rubin Grandis

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Head and neck squamous cell carcinomas (HNSCC) are characterized by upregulation of the epidermal growth factor receptor (EGFR), where EGFR serves as a potential therapeutic target. We previously reported that a gastrin-releasing peptide/gastrin-releasing peptide receptor (GRP/GRPR) autocrine growth pathway is activated early in HNSCC carcinogenesis. In the present study, we examined the mechanism of EGFR activation by GRP/GRPR in HNSCC proliferation. In HNSCC cells that express elevated levels of both GRPR and EGFR, we found that GRP induced rapid phosphorylation of EGFR as well as p44/42-MAPK activation. Using several EGFR-specific tyrosine kinase inhibitors and cells derived from EGFR knockout mice, we demonstrated that GRP-induced p44/42-MAPK activation was dependent upon EGFR activation. Further investigation demonstrated that cleavage of transforming growth factor-alpha (TGF-α) by matrix metalloproteinases mediated GRP-induced MAPK activation. In addition, HNSCC proliferation stimulated by GRP was eliminated upon specific inhibition of EGFR or MEK, and GRP failed to stimulate proliferation in EGFR-deficient cells. These results imply that the mitogenic effects of GRP in HNSCC are mediated by extracellular release of TGF-α and require the activation of an EGFR-dependent MEK/MAPK-dependent pathway.

Original languageEnglish (US)
Pages (from-to)6183-6193
Number of pages11
JournalOncogene
Volume22
Issue number40
DOIs
StatePublished - Sep 18 2003
Externally publishedYes

Fingerprint

Gastrin-Releasing Peptide
Head and Neck Neoplasms
Epidermal Growth Factor Receptor
Epithelial Cells
Bombesin Receptors
Transforming Growth Factor alpha
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase Kinases
Cell Proliferation
Matrix Metalloproteinases
Knockout Mice
Protein-Tyrosine Kinases
Carcinoma, squamous cell of head and neck
Carcinogenesis
Up-Regulation

Keywords

  • EGFR transactivation
  • G-protein-coupled receptor
  • GRPR
  • Head and neck cancer
  • TGF-α

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. / Lui, Vivian Wai Yan; Thomas, Sufi Mary; Zhang, Qing; Wentzel, Abbey Lynn; Siegfried, Jill Marie; Li, Joyce Yan; Grandis, Jennifer Rubin.

In: Oncogene, Vol. 22, No. 40, 18.09.2003, p. 6183-6193.

Research output: Contribution to journalArticle

Lui, Vivian Wai Yan ; Thomas, Sufi Mary ; Zhang, Qing ; Wentzel, Abbey Lynn ; Siegfried, Jill Marie ; Li, Joyce Yan ; Grandis, Jennifer Rubin. / Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. In: Oncogene. 2003 ; Vol. 22, No. 40. pp. 6183-6193.
@article{cf5ec495f14f489a853529ef4db41edc,
title = "Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor",
abstract = "Head and neck squamous cell carcinomas (HNSCC) are characterized by upregulation of the epidermal growth factor receptor (EGFR), where EGFR serves as a potential therapeutic target. We previously reported that a gastrin-releasing peptide/gastrin-releasing peptide receptor (GRP/GRPR) autocrine growth pathway is activated early in HNSCC carcinogenesis. In the present study, we examined the mechanism of EGFR activation by GRP/GRPR in HNSCC proliferation. In HNSCC cells that express elevated levels of both GRPR and EGFR, we found that GRP induced rapid phosphorylation of EGFR as well as p44/42-MAPK activation. Using several EGFR-specific tyrosine kinase inhibitors and cells derived from EGFR knockout mice, we demonstrated that GRP-induced p44/42-MAPK activation was dependent upon EGFR activation. Further investigation demonstrated that cleavage of transforming growth factor-alpha (TGF-α) by matrix metalloproteinases mediated GRP-induced MAPK activation. In addition, HNSCC proliferation stimulated by GRP was eliminated upon specific inhibition of EGFR or MEK, and GRP failed to stimulate proliferation in EGFR-deficient cells. These results imply that the mitogenic effects of GRP in HNSCC are mediated by extracellular release of TGF-α and require the activation of an EGFR-dependent MEK/MAPK-dependent pathway.",
keywords = "EGFR transactivation, G-protein-coupled receptor, GRPR, Head and neck cancer, TGF-α",
author = "Lui, {Vivian Wai Yan} and Thomas, {Sufi Mary} and Qing Zhang and Wentzel, {Abbey Lynn} and Siegfried, {Jill Marie} and Li, {Joyce Yan} and Grandis, {Jennifer Rubin}",
year = "2003",
month = "9",
day = "18",
doi = "10.1038/sj.onc.1206720",
language = "English (US)",
volume = "22",
pages = "6183--6193",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "40",

}

TY - JOUR

T1 - Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor

AU - Lui, Vivian Wai Yan

AU - Thomas, Sufi Mary

AU - Zhang, Qing

AU - Wentzel, Abbey Lynn

AU - Siegfried, Jill Marie

AU - Li, Joyce Yan

AU - Grandis, Jennifer Rubin

PY - 2003/9/18

Y1 - 2003/9/18

N2 - Head and neck squamous cell carcinomas (HNSCC) are characterized by upregulation of the epidermal growth factor receptor (EGFR), where EGFR serves as a potential therapeutic target. We previously reported that a gastrin-releasing peptide/gastrin-releasing peptide receptor (GRP/GRPR) autocrine growth pathway is activated early in HNSCC carcinogenesis. In the present study, we examined the mechanism of EGFR activation by GRP/GRPR in HNSCC proliferation. In HNSCC cells that express elevated levels of both GRPR and EGFR, we found that GRP induced rapid phosphorylation of EGFR as well as p44/42-MAPK activation. Using several EGFR-specific tyrosine kinase inhibitors and cells derived from EGFR knockout mice, we demonstrated that GRP-induced p44/42-MAPK activation was dependent upon EGFR activation. Further investigation demonstrated that cleavage of transforming growth factor-alpha (TGF-α) by matrix metalloproteinases mediated GRP-induced MAPK activation. In addition, HNSCC proliferation stimulated by GRP was eliminated upon specific inhibition of EGFR or MEK, and GRP failed to stimulate proliferation in EGFR-deficient cells. These results imply that the mitogenic effects of GRP in HNSCC are mediated by extracellular release of TGF-α and require the activation of an EGFR-dependent MEK/MAPK-dependent pathway.

AB - Head and neck squamous cell carcinomas (HNSCC) are characterized by upregulation of the epidermal growth factor receptor (EGFR), where EGFR serves as a potential therapeutic target. We previously reported that a gastrin-releasing peptide/gastrin-releasing peptide receptor (GRP/GRPR) autocrine growth pathway is activated early in HNSCC carcinogenesis. In the present study, we examined the mechanism of EGFR activation by GRP/GRPR in HNSCC proliferation. In HNSCC cells that express elevated levels of both GRPR and EGFR, we found that GRP induced rapid phosphorylation of EGFR as well as p44/42-MAPK activation. Using several EGFR-specific tyrosine kinase inhibitors and cells derived from EGFR knockout mice, we demonstrated that GRP-induced p44/42-MAPK activation was dependent upon EGFR activation. Further investigation demonstrated that cleavage of transforming growth factor-alpha (TGF-α) by matrix metalloproteinases mediated GRP-induced MAPK activation. In addition, HNSCC proliferation stimulated by GRP was eliminated upon specific inhibition of EGFR or MEK, and GRP failed to stimulate proliferation in EGFR-deficient cells. These results imply that the mitogenic effects of GRP in HNSCC are mediated by extracellular release of TGF-α and require the activation of an EGFR-dependent MEK/MAPK-dependent pathway.

KW - EGFR transactivation

KW - G-protein-coupled receptor

KW - GRPR

KW - Head and neck cancer

KW - TGF-α

UR - http://www.scopus.com/inward/record.url?scp=0142025133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142025133&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206720

DO - 10.1038/sj.onc.1206720

M3 - Article

C2 - 13679857

AN - SCOPUS:0142025133

VL - 22

SP - 6183

EP - 6193

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 40

ER -